JP2015512923A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015512923A5 JP2015512923A5 JP2015504946A JP2015504946A JP2015512923A5 JP 2015512923 A5 JP2015512923 A5 JP 2015512923A5 JP 2015504946 A JP2015504946 A JP 2015504946A JP 2015504946 A JP2015504946 A JP 2015504946A JP 2015512923 A5 JP2015512923 A5 JP 2015512923A5
- Authority
- JP
- Japan
- Prior art keywords
- cushing
- combination
- combination according
- syndrome
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261623117P | 2012-04-12 | 2012-04-12 | |
| US61/623,117 | 2012-04-12 | ||
| PCT/EP2013/057515 WO2013153129A1 (en) | 2012-04-12 | 2013-04-10 | Combination of somatostatin-analogs with 11beta-hydroxylase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015512923A JP2015512923A (ja) | 2015-04-30 |
| JP2015512923A5 true JP2015512923A5 (enExample) | 2016-05-19 |
| JP6383352B2 JP6383352B2 (ja) | 2018-08-29 |
Family
ID=48289057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015504946A Active JP6383352B2 (ja) | 2012-04-12 | 2013-04-10 | ソマトスタチンアナログの１１ベータ−水酸化酵素阻害剤との組合せ |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9333234B2 (enExample) |
| EP (1) | EP2836228B1 (enExample) |
| JP (1) | JP6383352B2 (enExample) |
| KR (1) | KR102136214B1 (enExample) |
| CN (1) | CN104321074B (enExample) |
| AU (1) | AU2013246908B2 (enExample) |
| BR (1) | BR112014025058B1 (enExample) |
| CA (1) | CA2869442C (enExample) |
| ES (1) | ES2980806T3 (enExample) |
| IN (1) | IN2014DN09240A (enExample) |
| MX (1) | MX362533B (enExample) |
| RU (1) | RU2663455C2 (enExample) |
| WO (1) | WO2013153129A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2523731T3 (pl) * | 2010-01-14 | 2019-04-30 | Novartis Ag | Zastosowanie środka modyfikującego hormon nadnerczy |
| DK3166596T3 (en) * | 2014-07-07 | 2018-09-10 | Novartis Ag | Pharmaceutical dosage forms |
| WO2016048984A1 (en) * | 2014-09-25 | 2016-03-31 | Cortendo Ab (Publ) | Methods and compositions for the treatment of cushing's syndrome using 2s, 4r ketoconazole |
| MX2018008849A (es) | 2016-01-19 | 2019-01-31 | Corcept Therapeutics Inc | Diagnostico diferencial de sindrome de cushing ectopico. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002521456A (ja) * | 1998-07-30 | 2002-07-16 | ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス | ソマトスタチン類似体の使用法 |
| WO2002081499A2 (en) * | 2001-04-09 | 2002-10-17 | The Administrators Of The Tulane Educational Fund | Somatostatin agonists |
| GT200600381A (es) * | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
| ES2472446T3 (es) * | 2009-11-30 | 2014-07-01 | Novartis Ag | Derivados de imidazol como inhibidores de aldosterona sintasa |
| PL2523731T3 (pl) * | 2010-01-14 | 2019-04-30 | Novartis Ag | Zastosowanie środka modyfikującego hormon nadnerczy |
| WO2013131879A1 (en) * | 2012-03-07 | 2013-09-12 | Novartis Ag | New application for pasireotide |
-
2013
- 2013-04-10 EP EP13720275.0A patent/EP2836228B1/en active Active
- 2013-04-10 AU AU2013246908A patent/AU2013246908B2/en not_active Ceased
- 2013-04-10 IN IN9240DEN2014 patent/IN2014DN09240A/en unknown
- 2013-04-10 JP JP2015504946A patent/JP6383352B2/ja active Active
- 2013-04-10 US US14/391,416 patent/US9333234B2/en active Active
- 2013-04-10 CA CA2869442A patent/CA2869442C/en active Active
- 2013-04-10 CN CN201380027076.7A patent/CN104321074B/zh active Active
- 2013-04-10 KR KR1020147031324A patent/KR102136214B1/ko not_active Expired - Fee Related
- 2013-04-10 WO PCT/EP2013/057515 patent/WO2013153129A1/en not_active Ceased
- 2013-04-10 RU RU2014145351A patent/RU2663455C2/ru active
- 2013-04-10 MX MX2014012321A patent/MX362533B/es active IP Right Grant
- 2013-04-10 ES ES13720275T patent/ES2980806T3/es active Active
- 2013-04-10 BR BR112014025058-8A patent/BR112014025058B1/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010270124A5 (enExample) | ||
| JP2014528901A5 (enExample) | ||
| JP2016530280A5 (enExample) | ||
| WO2009043476A3 (en) | Neuromedin s as a therapeutic agent | |
| JP2015512418A5 (enExample) | ||
| JP2020521797A5 (enExample) | ||
| JP2011225596A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| WO2009043448A3 (en) | Neuromedin u-25 and neuromedin s as therapeutic agents | |
| JP2016508134A5 (enExample) | ||
| JP2014077003A5 (enExample) | ||
| RU2016141570A (ru) | Комбинации ингибитора fgfr и ингибитора igf1r | |
| JP2016516016A5 (enExample) | ||
| JP2015522018A5 (enExample) | ||
| JP2017532343A5 (enExample) | ||
| JP2013543491A5 (enExample) | ||
| EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
| HK1206246A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| JP2017501154A5 (enExample) | ||
| JP2013541583A5 (enExample) | ||
| JP2015512923A5 (enExample) | ||
| JP2016527202A5 (enExample) | ||
| JP2015516419A5 (enExample) | ||
| JP2015522603A5 (enExample) |